F-Prime Capital Partners

F-Prime Capital Partners is a global venture capital firm investing in healthcare and technology sectors. With over $3 billion under management and a global portfolio of more than 200 companies, F-Prime Capital Partners focuses on therapeutics, medical technology, and healthcare IT & services across various stages of development. The firm has a history of backing groundbreaking companies, including Denali, Beam, Innovent, Orchard, and Sana.

The firm's investment strategy is stage-agnostic, encompassing seed, early-stage, late-stage, growth, and pre-IPO investments. F-Prime Capital Partners has a diverse geographical focus, investing in countries such as the United States, China, India, Japan, the United Kingdom, Germany, France, Italy, Spain, Australia, Canada, South Korea, Singapore, Israel, Brazil, Mexico, South Africa, Russia, Saudi Arabia, and the United Arab Emirates. This broad reach allows the firm to identify and support innovative companies worldwide.

F-Prime Capital Partners' portfolio includes a wide range of industries, such as biotechnology, medical devices, healthcare IT, pharmaceuticals, diagnostics, healthcare services, digital health, consumer health, medtech, healthtech, life sciences, healthcare, technology, artificial intelligence, and machine learning. The firm's commitment to these sectors reflects its dedication to fostering innovation and improving healthcare outcomes globally.

F-Prime Capital Partners' investment philosophy centers on supporting entrepreneurs dedicated to creating positive change in the world. The firm leverages its extensive network and expertise to help portfolio companies navigate challenges and achieve success. With a focus on transformative impact, F-Prime Capital Partners continues to be a significant player in the venture capital landscape, driving advancements in healthcare and technology sectors.